RxTrials Announces Appointment Of Adam Chasse To President

ELLICOTT CITY, Md., Oct. 8, 2014 /PRNewswire/ -- RxTrials, a leading Investigative Site Network (ISN) and consulting firm, today announces the appointment of Adam Chasse to President.

"Adam has served as Chief Operating Officer of RxTrials where he has consistently proven his ability to successfully drive innovation, and lead large scale initiatives. Additionally he has repeatedly demonstrated his innate capacity to develop and execute on a strategic vision for the company, growing RxTrials' site network from 7 to 14 sites and expanding beyond the US into South America. His appointment to President will continue to strengthen RxTrials' position as an industry leader," states Christine Pierre, founder of RxTrials.

"This is an exciting time to be leading RxTrials, as we have such a unique blend of healthcare, site management, and CRO/pharma experience among our management and staff," adds Chasse. "The industry is aligning more strategically with site networks, which has led to RxTrials being able to support their studies in innovative ways that take full advantage of our team's diverse professional background."

Adam joined RxTrials in 2011 as the Vice President of Corporate Development, and quickly advanced to the position of Chief Operating Officer. His 16 previous years of experience in the pharmaceutical development industry positioned him as a superb fit for RxTrials; Adam was previously the Global Head of Prime Sites at Quintiles. Adam earned his Master of Healthcare Administration degree from the University of North Carolina at Chapel Hill.

Adam assumed his role as RxTrials President in October, and will remain based in Raleigh, North Carolina.

About RxTrials

RxTrials, Inc. (www.rxtrialsinc.com) is a pioneer in the site management industry and has provided expertise to its network of premier clinical research sites for more than 20 years. RxTrials has conducted thousands of Phase II-III studies and numerous vaccine studies that have helped bring new drugs, vaccines, and medical devices to market. The company offers the industry a single point of contact for study procurement, site feasibility, and budget and contract negotiations as well as centralized administrative, compliance, and management services. RxTrials is also a leading consulting company that provides strategic, operational, and administrative solutions to research sites, sponsors, and CROs.

Suggested Articles

The data, from two patients with severe blood disorders, are "promising” for what could be a one-and-done treatment, Cantor Fitzgerald analysts wrote.

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.